Abbott Laboratories (ABT) reported third-quarter 2024 adjusted earnings per share (EPS) of $1.21, which beat the Zacks Consensus Estimate by 0.8%. The figure also improved 6.1% from the prior-year quarter’s level.GAAP EPS came in at 94 cents, up 14.6% year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, ABT stock edged up 0.03% during the pre-market trading today.ABT’s Q3 RevenuesWorldwide sales of $10.64 billion were up 4.9% year over ye ...